ATAI Life Sciences NVNASDAQ:ATAI
- LAST PRICE1.0800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0800/ 10
- Ask / Lots1.1100/ 1
- Open / Previous Close1.1000 / 1.0800
- Day Range
- 52 Week Range
- Volume537,159
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATAI |
|---|---|---|
| 09:32 ET | 9947 | 1.11 |
| 09:33 ET | 200 | 1.11 |
| 09:35 ET | 21067 | 1.0803 |
| 09:37 ET | 10248 | 1.08 |
| 09:39 ET | 100 | 1.071 |
| 09:42 ET | 837 | 1.08 |
| 09:44 ET | 150 | 1.0711 |
| 09:46 ET | 4281 | 1.075 |
| 09:48 ET | 42471 | 1.06 |
| 09:50 ET | 3784 | 1.06 |
| 09:51 ET | 2938 | 1.055 |
| 09:53 ET | 3746 | 1.0529 |
| 09:55 ET | 2616 | 1.055 |
| 09:57 ET | 3700 | 1.065 |
| 10:00 ET | 1200 | 1.065 |
| 10:02 ET | 1100 | 1.06 |
| 10:06 ET | 7892 | 1.0716 |
| 10:08 ET | 200 | 1.075 |
| 10:09 ET | 9575 | 1.065 |
| 10:11 ET | 3200 | 1.07 |
| 10:13 ET | 23481 | 1.0705 |
| 10:15 ET | 250 | 1.0789 |
| 10:18 ET | 1342 | 1.07 |
| 10:20 ET | 4967 | 1.07 |
| 10:22 ET | 2274 | 1.06 |
| 10:24 ET | 1039 | 1.0695 |
| 10:26 ET | 14269 | 1.085 |
| 10:27 ET | 52461 | 1.1 |
| 10:29 ET | 4800 | 1.1 |
| 10:31 ET | 300 | 1.0924 |
| 10:33 ET | 11329 | 1.08 |
| 10:40 ET | 100 | 1.085 |
| 10:42 ET | 100 | 1.085 |
| 10:44 ET | 138 | 1.0809 |
| 10:47 ET | 1850 | 1.09 |
| 11:02 ET | 200 | 1.09 |
| 11:03 ET | 100 | 1.09 |
| 11:05 ET | 3549 | 1.085 |
| 11:12 ET | 300 | 1.0871 |
| 11:16 ET | 1811 | 1.0899 |
| 11:18 ET | 3499 | 1.09 |
| 11:20 ET | 100 | 1.09 |
| 11:21 ET | 822 | 1.09 |
| 11:23 ET | 4100 | 1.095 |
| 11:25 ET | 3400 | 1.095 |
| 11:27 ET | 100 | 1.095 |
| 11:30 ET | 3424 | 1.0922 |
| 11:36 ET | 4000 | 1.0901 |
| 11:39 ET | 229 | 1.09 |
| 11:41 ET | 182 | 1.095 |
| 11:43 ET | 800 | 1.095 |
| 11:50 ET | 1000 | 1.095 |
| 11:52 ET | 400 | 1.095 |
| 11:56 ET | 3300 | 1.1 |
| 11:59 ET | 3500 | 1.0911 |
| 12:06 ET | 274 | 1.09 |
| 12:08 ET | 10700 | 1.095 |
| 12:10 ET | 750 | 1.095 |
| 12:12 ET | 100 | 1.095 |
| 12:15 ET | 26800 | 1.09 |
| 12:17 ET | 100 | 1.095 |
| 12:21 ET | 100 | 1.095 |
| 12:30 ET | 561 | 1.0909 |
| 12:37 ET | 100 | 1.0994 |
| 12:42 ET | 13100 | 1.095 |
| 12:44 ET | 100 | 1.095 |
| 12:46 ET | 1000 | 1.095 |
| 12:51 ET | 600 | 1.095 |
| 12:55 ET | 500 | 1.0909 |
| 01:00 ET | 1050 | 1.095 |
| 01:04 ET | 2000 | 1.1 |
| 01:06 ET | 8672 | 1.08 |
| 01:08 ET | 22176 | 1.065 |
| 01:09 ET | 450 | 1.06 |
| 01:13 ET | 500 | 1.0693 |
| 01:15 ET | 200 | 1.065 |
| 01:20 ET | 194 | 1.0694 |
| 01:24 ET | 500 | 1.0688 |
| 01:27 ET | 280 | 1.06 |
| 01:29 ET | 168 | 1.07 |
| 01:33 ET | 2000 | 1.06 |
| 01:36 ET | 43705 | 1.069 |
| 01:38 ET | 3900 | 1.065 |
| 01:40 ET | 1348 | 1.0692 |
| 01:42 ET | 400 | 1.065 |
| 01:45 ET | 133 | 1.0612 |
| 01:51 ET | 3513 | 1.07 |
| 01:54 ET | 2934 | 1.075 |
| 01:56 ET | 100 | 1.075 |
| 02:03 ET | 600 | 1.075 |
| 02:05 ET | 4894 | 1.075 |
| 02:07 ET | 700 | 1.075 |
| 02:09 ET | 1323 | 1.0709 |
| 02:18 ET | 900 | 1.08 |
| 02:20 ET | 840 | 1.08 |
| 02:23 ET | 200 | 1.075 |
| 02:25 ET | 350 | 1.075 |
| 02:27 ET | 186 | 1.075 |
| 02:30 ET | 100 | 1.0799 |
| 02:32 ET | 2786 | 1.085 |
| 02:34 ET | 800 | 1.0891 |
| 02:38 ET | 2600 | 1.085 |
| 02:43 ET | 300 | 1.0895 |
| 02:48 ET | 300 | 1.0801 |
| 02:54 ET | 100 | 1.085 |
| 02:56 ET | 100 | 1.085 |
| 02:57 ET | 100 | 1.085 |
| 02:59 ET | 648 | 1.085 |
| 03:01 ET | 100 | 1.085 |
| 03:06 ET | 1885 | 1.0809 |
| 03:08 ET | 399 | 1.085 |
| 03:15 ET | 1500 | 1.0898 |
| 03:24 ET | 100 | 1.085 |
| 03:28 ET | 6754 | 1.082 |
| 03:30 ET | 700 | 1.085 |
| 03:32 ET | 200 | 1.085 |
| 03:35 ET | 455 | 1.09 |
| 03:39 ET | 100 | 1.085 |
| 03:42 ET | 2400 | 1.085 |
| 03:44 ET | 1000 | 1.085 |
| 03:46 ET | 320 | 1.085 |
| 03:48 ET | 603 | 1.085 |
| 03:51 ET | 733 | 1.085 |
| 03:53 ET | 531 | 1.085 |
| 03:55 ET | 950 | 1.09 |
| 03:57 ET | 3802 | 1.08 |
| 04:00 ET | 19744 | 1.08 |
Oct 15, 2024
atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit, from 8:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
8:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ATAI Life Sciences NV | 181.2M | -2.8x | --- |
Instil Bio Inc | 179.7M | -1.4x | --- |
Atossa Therapeutics Inc | 177.3M | -6.8x | --- |
Acumen Pharmaceuticals Inc | 177.2M | -2.7x | --- |
Immutep Ltd | 267.1M | -7.8x | --- |
Cardiff Oncology Inc | 174.1M | -4.0x | --- |
Company Information
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Contact Information
- Headquarters
- Wallstrasse 16Berlin, Germany 10179
- Phone
- 892-153-9035
- Fax
- ---
Executives
- Chairman of the Supervisory Board
- Christian Angermayer
- Co-Chief Executive Officer
- Florian Brand
- Co-Chief Executive Officer
- Srinivas Rao
- Chief Financial Officer
- Anne Johnson
- Chief Business Officer
- Sahil Kirpekar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $181.2M |
|---|---|
Revenue (TTM) | $378.0K |
Shares Outstanding | 167.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-0.39 |
Book Value | $1.46 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 479.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29,407.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
